A survey on the status of lipid-lowering therapy in 180 hypercholesterolemic patients / 中华流行病学杂志
Chinese Journal of Epidemiology
; (12): 378-372, 2002.
Article
in Zh
| WPRIM
| ID: wpr-244257
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To determine the percentage of hypercholesterolemic patients who had met the criteria as total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), defined by the Chinese National Recommendations for Prevention and Treatment of Dyslipidemia.</p><p><b>METHODS</b>Adult patients with hypercholesterolemia, who had been receiving the same lipid-lowering therapy for at least 2 months, were enrolled. Lipid levels were determined at the time of enrollment, to assess whether the patients' lipid levels had reached the criteria for treatment. Patients' cardiovascular risk factors and lipid-lowering treatments were also collected.</p><p><b>RESULTS</b>One hundred and eighty patients with mean age of 65.8 were studied. Of these, 6.7% had no risk factors and no definite disease of atherosclerosis (low-risk group), 65.5% had risk factors but no documented atherosclerosis (high-risk group), and 27.8% had established atherosclerosis diseases or diabetes mellitus. Overall, only 44% of patients achieved both TC and LDL-C target levels. The success rates were higher among low and high-risk groups than that among patients with atherosclerosis or diabetes mellitus. The relationship between four different lipid-lowering drug therapies and successful patient outcome was also investigated. The success rates were 51.8% for simvastatin, 42.9% for pravastatin, 31.6% for fluvastatin, 12.5% for other drugs respectively.</p><p><b>CONCLUSION</b>More than half of the hypercholesterolemic patients receiving lipid-lowering therapy had not achieved TC and LDL-C target levels. Data from this study indicated that a significant gap still existed between dyslipidemia prevention principles and clinical practices, suggesting that more aggressive treatment of dyslipidemia is needed.</p>
Full text:
1
Database:
WPRIM
Main subject:
Blood
/
Cholesterol
/
Therapeutic Uses
/
Drug Therapy
/
Hypercholesterolemia
/
Cholesterol, LDL
/
Anticholesteremic Agents
Type of study:
Guideline
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
Zh
Journal:
Chinese Journal of Epidemiology
Year:
2002
Document type:
Article